Latest news
Aledade Names Daren Thayne CTO and Josh Mandel Chief Scientist - The Healthcare Technology Report.The Healthcare Technology Report. · Thu, 06 Aug 2026 12:02:11 GMTCamp4 Therapeutics CEO Josh Mandel-Brehm acquires 6,551 common shares for $10,809.15 - BitgetBitget · Wed, 05 Aug 2026 21:53:17 GMTInsider Purchase: Chief Executive Officer of $CAMP Buys 6,551 Shares - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 21:47:00 GMTHealthcare Moves: A Monthly Summary of Hires, Exits and Layoffs - MedCity NewsMedCity News · Fri, 31 Jul 2026 07:00:00 GMT